| Literature DB >> 24039870 |
Frans T Smits1, Henk J Brouwer, Aeilko H Zwinderman, Marjan van den Akker, Ben van Steenkiste, Jacob Mohrs, Aart H Schene, Henk C van Weert, Gerben Ter Riet.
Abstract
BACKGROUND: Frequent attenders are patients who visit their general practitioner exceptionally frequently. Frequent attendance is usually transitory, but some frequent attenders become persistent. Clinically, prediction of persistent frequent attendance is useful to target treatment at underlying diseases or problems. Scientifically it is useful for the selection of high-risk populations for trials. We previously developed a model to predict which frequent attenders become persistent. AIM: To validate an existing prediction model for persistent frequent attendance that uses information solely from General Practitioners' electronic medical records.Entities:
Mesh:
Year: 2013 PMID: 24039870 PMCID: PMC3764153 DOI: 10.1371/journal.pone.0073125
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Original prediction rule [14]: Associations between five predictors and persistent frequent attendance (pFA), the dependent variable.
| Predictor | (adjusted) Odds ratio | 95% confidence interval limits |
| Age | 0.99 | 0.98–1.00 |
| No. of active problems | 1.13 | 1.05–1.22 |
| Any chronic somatic illness | 1.55 | 1.25–1.93 |
| Any psychological problem | 1.72 | 1.30–2.27 |
| Average monthly No. analgesics prescriptions: none | 1 | Reference |
| 1–4 | 1.77 | 1.41–2.23 |
| >4 | 2.06 | 1.59–2.66 |
Based on 3045 observations; 470 pFAs (dependent variable = 1);
modeled as a continuous variable; All other variables were modeled as dummies.
Comparison of the three databases.
| A’dam I | A’dam II | SMILE | ||
| Time period | 2003–2005 | 2009–2011 | 2007–2009 | |
| Patients n | 28,680 | 40,320 | 54,620 | |
| Frequent attenders n | 3,045 | 4,032 | 5,462 | |
| Persistent Frequent Attenders n (%) | 470 (15%) | 629 (16%) | 1,107 (20%) | |
| ‘Lost to follow up’ n (%) | 436 (14.3) | 608 (15.1) | 199 (3.6) | |
| Mean age (SD | 42.6 (18.2) | 47.9 (18.5) | 45.9 (18.8) | |
| Females n (%) | 1,566 (51) | 2,179 (54) | 2,640 (48) | |
| Consultations of pFAs | 10.2 | 11.8 | 7.7 | |
| Problems on the problem list | ||||
| Active problems (Frequent Attenders) n (SD) | 2.03 (2.16) | 2.68 (2.70) | 1.70 (1.55) | |
| Any chronic somatic illness n (%) | 1,259(41) | 1,906(47) | 2,768 (50) | |
| Any psychological or social problem n (%) | 690 (23) | 1,028 (26) | 2,781 (51) | |
| Any Medically Unexplained Symptoms n (%) | 391 (13) | 610 (15) | 98 (2) | |
| Prescriptions of analgesics mean n/month (%) | 0 | 1,484(49) | 1,889 (49) | 2,759 (51) |
| 1–4 | 1,061 (35) | 1,446 (36) | 2,703(50) | |
| >4 | 500 (16) | 597 (15) | ||
| Any psychoactive medication n (%) | 938 (31) | 1,230 (31) | 1,775 (33) | |
| Prescriptions of antibiotics mean n/month (%) | 0 | 1,976 (65) | 2,374 (59) | 3,120 (57) |
| 1–2 | 814 (27) | 1,172 (29) | 2,342 (43) | |
| >2 | 255 (8) | 486 (12) |
n indicates number.
SD indicates standard deviation.
pFAs indicates persistent Frequent attenders, frequent attenders during 3 years.
Respectively in 2005 (A’dam I), 2011 (A’dam II) and 2009 (SMILE).
A’dam indicates the Amsterdam I cohort.
Figure 1Flow chart of the 3 databases.
Discrimination and calibration on external validation of the original prognostic index to the Amsterdam II and SMILE cohorts.
| Amsterdam I | Amsterdam II | SMILE | ||||
| number ofFAs/pFAs | 3,045/470 | 4,032/629 | 5,462/1107 | |||
|
| ||||||
| C-statistics(95% CI) | 0.67 | 0.64–0.69 | 0.62 | 0.60–0.65 | 0.63 | 0.61–0.65 |
| Positive predictive value | 0.27 | 0.22 | 0.27 | |||
| Negative predictivevalue | 0.90 | 0.89 | 0.86 | |||
|
| ||||||
| C-statistics(95% CI) | 0.67 | 0.64–0.69 | 0.64 | 0.61–0.66 | 0.63 | 0.62–0.65 |
| Positive predictivevalue | 0.27 | 0.22 | 0.27 | |||
| Negative predictivevalue | 0.90 | 0.89 | 0.86 | |||
|
| ||||||
| C-statistics(95% CI) | 0.67 | 0.65–0.70 | 0.65 | 0.62–0.67 | 0.65 | 0.63–0.66 |
| Positive predictivevalue | 0.26 | 0.23 | 0.26 | |||
| Negative predictivevalue | 0.90 | 0.89 | 0.88 | |||
|
| ||||||
| Slope (SE) | 0.99 | 0.08 | 0.656 | 0.07 | 0.83 | 0.06 |
(p)FAs: (persistent) Frequent Attenders: frequently attending patients during 1 and 3 years, respectively.
Concordance statistics (95% confidence interval).
Female sex; any medically unexplained symptoms; any psychoactive medication; mean monthly number of prescriptions of antibiotics.
Ideally, the slope should be 1, which indicates perfect calibration of predicted and observed risks. Values <1 indicate overoptimism (shrinkage), that is, high risks are overestimated, while low risks are underestimated.
using a model with shrunken coefficients of the original model (shrinkage coefficient 0.993).
Sensitivity, specificity, likelihood ratios and positive and negative predictive values were calculated at the value where their sum was maximal (Q-point of the ROC curve).
Figure 2Histograms showing the predicted values based on the model predictions for the three cohorts, Amsterdam I (the original (derivation) cohort) and the two external validation cohorts.
Histograms showing the predicted values based on the model predictions for the three cohorts, Amsterdam I (the original (derivation) cohort) and the two external validation cohorts, Amsterdam II and SMILE. The graphs illustrate the slight overoptimism of the original model and the shrinkage of the distributions, that is, the tails of the AMC II and SMILE cohort distributions are slightly closer to the center and predicted values smaller than 7 percent or greater than 54% no longer occur on external validation. Y-axes are frequencies.
Figure 3Hosmer Lemeshow plots: Observed versus predicted risk for persistent frequent attendance.
In these Hosmer-Lemeshow calibration plots, each circle represents the observed mean probability of becoming a persistent frequent attender (pFA) within a decile of patients after all patients were ordered from lowest to highest predicted probability. As usual, the Hosmer Lemeshow calibration plot in the top left hand corner shows a good match between predicted and observed risks in the derivation cohort (Amsterdam I) as all circles are close to the diagonal of perfect calibration. On external validation in the Amsterdam II cohort (top right hand graph), eight out of ten predicted values were higher than those observed and those in deciles 5, 8 and 10 (extreme right hand circle) in particular. On external validation in the SMILE cohort, predicted probabilities matched the observed ones well, except for the two highest deciles, 9 and 10. The small p-values are also partly caused by the large sample size so that small mismatches become statistically significant. Note that the vertical distance to the diagonal represents the mismatch between predicted and observed pFA probabilities.